BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R/NLRP3 and MyD88/NF-κB signaling in DSS-induced colitis in rats-Reference-Cited by-同舟云学术

BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R/NLRP3 and MyD88/NF-κB signaling in DSS-induced colitis in rats

Published:2021-04 Issue: Volume:270 Page:119123
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Saber Sameh,Youssef Mahmoud E.,Sharaf Hossam,Amin Noha A.,El-Shedody Ruwyda,Aboutouk Farah H.,El-Galeel Yumna Abd,El-Hefnawy Amr,Shabaka Dina,Khalifa Arwa,Saleh Renad A.,Osama Donya,El-Zoghby Ghada,Gobba Naglaa A.

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference66 articles.

1. Telmisartan ameliorates dextran sodium sulfate-induced colitis in rats by modulating NF-κB signalling in the context of PPARγ agonistic activity;Saber;Arch. Biochem. Biophys.,2019

2. Novel complementary coloprotective effects of metformin and MCC950 by modulating HSP90/NLRP3 interaction and inducing autophagy in rats;Saber;Inflammopharmacology.,2020

3. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders;Magro;J Crohns Colitis.,2017

4. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation;Kelley;Int. J. Mol. Sci.,2019

5. Novel complementary antitumour effects of celastrol and metformin by targeting IκBκB, apoptosis and NLRP3 inflammasome activation in diethylnitrosamine-induced murine hepatocarcinogenesis;Saber;Cancer Chemother. Pharmacol.,2020

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Administration of an AAV vector coding for a P2X7-blocking nanobody-based biologic ameliorates colitis in mice;Journal of Nanobiotechnology;2024-01-11

2. The research progression of direct NLRP3 inhibitors to treat inflammatory disorders;Cellular Immunology;2024-01

3. P2 purinergic receptors regulate the progression of colorectal cancer;Purinergic Signalling;2023-12-28

4. NLRP3 inhibitors: Unleashing their therapeutic potential against inflammatory diseases;Biochemical Pharmacology;2023-12

5. ATP ion channel P2X7 receptor as a regulatory molecule in the progression of colorectal cancer;European Journal of Medicinal Chemistry;2023-12